These data were in line with our recent study where samples from SARS‐CoV‐2‐unexposed donors or prostate cancer patients were also largely not enriched with SARS‐CoV‐2 spike glycoprotein‐specific CD8+ T cells.31 This evidence concerns the gene CD8A and Familial prostate cancer.